Caribou Biosciences, Inc. Common Stock (CRBU) is a publicly traded Healthcare sector company. As of October 6, 2026, CRBU trades at $0.61 with a market cap of $127.58M and a P/E ratio of -0.76. CRBU moved -4.62% today. Year to date, CRBU is -28.62%; over the trailing twelve months it is -51.50%. Its 52-week range spans $0.66 to $3.54. Analyst consensus is strong buy with an average price target of $7.67. Rallies surfaces CRBU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
3 analysts cover CRBU: 0 strong buy, 3 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $7.67.
| Metric | Value |
|---|---|
| Price | $0.61 |
| Market Cap | $127.58M |
| P/E Ratio | -0.76 |
| EPS | $-1.59 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.54 |
| 52-Week Low | $0.66 |
| Volume | 1.02M |
| Avg Volume | 0 |
| Revenue (TTM) | $11.16M |
| Net Income | $-148.13M |
| Gross Margin | 0.00% |
3 analysts cover CRBU: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $7.67.